 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
8 News |  |
- | LeukoScan (sulesomab) / Gilead
Journal: Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases. (Pubmed Central) - Sep 24, 2021
It is able to confirm or reject the presence of infection when results of anatomic imaging or culture remain inconclusive. Its diagnostic performance is not compromised by sterile inflammation occurring in the early post-operative period or in response to implanted prosthetic materials.
- | LeukoScan (sulesomab) / Gilead
Journal: Value of antigranulocyte scintigraphy with Tc-99m-sulesomab in diagnosing combat-related infections of the musculoskeletal system. (Pubmed Central) - Jun 9, 2021
Antigranulocyte scintigraphy using Tc-99m-sulesomab represented a highly suitable technique for diagnostically clarifying combat-related infections of the extremities. It is superior to CT in sensitivity, specificity, PPV, NPV and accuracy.
- | LeukoScan (sulesomab) / Gilead
Preclinical, Journal: Severe Anaphylaxis on Murine Antibodies in Sulesomab. (Pubmed Central) - Feb 7, 2021
It is superior to CT in sensitivity, specificity, PPV, NPV and accuracy. No abstract available
- | LeukoScan (sulesomab) / Gilead
Enrollment open: PLEIM: The Value of 99mTc-Leukoscan (clinicaltrials.gov) - Jun 20, 2017
P4, N=30, Recruiting, Sponsor: Hospices Civils de Lyon
No abstract available Not yet recruiting --> Recruiting
- | LeukoScan (sulesomab) / Gilead
New P4 trial: PLEIM: The Value of 99mTc-Leukoscan (clinicaltrials.gov) - Apr 13, 2017
P4, N=30, Not yet recruiting, Sponsor: Hospices Civils de Lyon
- LeukoScan (sulesomab) / Gilead
Enrollment change, Trial termination, Trial primary completion date: ISEOD: PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot (clinicaltrials.gov) - Oct 11, 2014
P=N/A, N=12, Terminated, Sponsor: Centre Hospitalier Universitaire de N?mes
Not yet recruiting --> Recruiting N=109 --> 12 | Recruiting --> Terminated | Trial primary completion date: Oct 2015 --> Nov 2014; The study has proven to be infeasible.
- LeukoScan (sulesomab) / Gilead
Trial initiation date: ISEOD: PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=109, Recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
N=109 --> 12 | Recruiting --> Terminated | Trial primary completion date: Oct 2015 --> Nov 2014; The study has proven to be infeasible. Initiation date: Jul 2012 --> Oct 2012
- LeukoScan (sulesomab) / Gilead
Enrollment open: ISEOD: PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot (clinicaltrials.gov) - Jul 25, 2012
P=N/A, N=109, Recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
Initiation date: Jul 2012 --> Oct 2012 Not yet recruiting --> Recruiting